Key Quantitative Details
- Number of equity shares to be issued: 17,70,710
- Face value per share: ₹5
- Issue price per share: ₹42
- Total consideration: ₹7,43,69,820
- Purpose: Conversion of unsecured loans from promoter and promoter group category
Compliance Requirements
- Must obtain statutory approvals under Companies Act, SEBI regulations, and other applicable laws
- Required to strengthen internal controls to monitor trades by proposed allottees
- Must obtain undertaking from allottees confirming no intra-day trading or sale until allotment date
- Responsibility solely on company to verify compliance with Regulation 167(6) of SEBI ICDR regulations
- Must make listing application within 20 days from date of allotment as per SEBI circular
- Non-compliance may impact listing of shares and attract fines
Parties Involved
- Issuer: Sampre Nutritions Limited
- Regulatory authority: BSE Limited
- Signatory for company: Brahma Gurbani, Managing Director (DIN: 00318180)
- BSE officials: Karan Shah (Deputy Manager), Janardhan Wagle (Deputy Vice President)
Financial Impact
The preferential issue will convert unsecured loans of ₹7,43,69,820 into equity capital, reducing debt and increasing share capital. Exact dilution percentage not quantified in disclosure.
Additional Requirements
- This in-principle approval does not constitute final listing approval
- Company must comply with post-issue formalities and listing requirements
- BSE reserves right to withdraw approval if information is found incomplete/incorrect/misleading/false
- Depositories will automatically release excess lock-in period of pre-preferential holding without requiring NOC from Exchange